In vitro assessment of mathematically-derived fractional flow reserve in coronary lesions with more than two sequential stenoses

Journal of Invasive Cardiology

Volumn 25, Issue 12, 2013, Pages 642-649

  Saito, Naritatsu ^a   Matsuo, Hitoshi ^b   Kawase, Yoshiaki ^b   Watanabe, Shin ^a   Bao, Bingyuan ^a   Yamamoto, Erika ^a   Watanabe, Hiroki ^a   Nakatsuma, Kenji ^a   Ueno, Katsumi ^b   Kimura, Takeshi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b GIFU HEART CENTER   (Japan)

Author keywords

Coronary stenosis; prediction

Indexed keywords

ARTICLE; CORONARY ARTERY BLOOD FLOW; FRACTIONAL FLOW RESERVE; MATHEMATICAL MODEL; BIOLOGICAL MODEL; BLOOD FLOW; COMPARATIVE STUDY; CORONARY ARTERY OBSTRUCTION; HUMAN; IN VITRO STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; STATISTICAL MODEL; THEORETICAL MODEL;

CORONARY STENOSIS; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; IN VITRO TECHNIQUES; LINEAR MODELS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; PREDICTIVE VALUE OF TESTS; REGIONAL BLOOD FLOW; REPRODUCIBILITY OF RESULTS;

EID: 84890029699     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Tonino PAL, De Bruyne B, Pijls NHJ, Siebert U, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360(3):213-224.
2. Pijls NH, Van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation. 1993;87(4):1354-1367. (Pubitemid 23110406)
3. Miller LH, Toklu B, Rauch J, Lorin JD, Lobach I, Sedlis SP. Very long-term clinical follow-up after fractional flow reserve-guided coronary revascularization. J Invasive Cardiol. 2012;24(7):309-315.
4. Pijls NH, De Bruyne B, Bech GJ, et al. Coronary pressure measurement to assess the hemodynamic significance of serial stenoses within one coronary artery: validation in humans. Circulation. 2000;102(19):2371-2377.
5. De Bruyne B, Pijls NHJ, Heyndrickx GR, Hodeige D, Kirkeeide R, Gould KL. Pressure-derived fractional flow reserve to assess serial epicardial stenoses: theoretical basis and animal validation. Circulation. 2000;101(15):1840-1847. (Pubitemid 30213107)
6. Shirai S, Kimura T, Nobuyoshi M, et al. Impact of multiple and long sirolimus-eluting stent implantation on 3-year clinical outcomes in the j-Cypher Registry. JACC Cardiovasc Interv. 2010;3(2):180-188.
7. Ahn J-M, Park D-W, Kim Y-H, et al. Comparison of resolute zotarolimus-eluting stents and sirolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES IV trial. Circ Cardiovasc Interv. 2012;5(5):633-640.
8. De la Torre Hernandez JM, Garcia Camarero T, Lerena P, et al. A real all-comers randomized trial comparing Xience Prime and Promus Element stents. J Invasive Cardiol. 2013;25(4):182-185.
9. Park S-J, Ahn J-M, Pijls NHJ, et al. Validation of functional state of coronary tandem lesions using computational flow dynamics. Am J Cardiol. 2012;110(11):1578-1584.
10. Pijls NHJ, Sels JW. Functional measurement of coronary stenosis. J Am Coll Cardiol. 2012;59(12):1045-1057.
11. Kim H-L, Koo B-K, Nam C-W, et al. Clinical and physiological outcomes of fractional flow reserve-guided percutaneous coronary intervention in patients with serial stenoses within one coronary artery. JACC Cardiovasc Interv. 2012;5(10):1013-1018.
12. Pijls NH, Bech GJ, El Gamal MI, et al. Quantification of recruitable coronary collateral blood flow in conscious humans and its potential to predict future ischemic events. J Am Coll Cardiol. 1995;25(7):1522-1528.